Cellular localization of platelet-activating factor (PAF) receptor in the rat brain was determined by (1) in situ hybridization,
, rise in intracellular Ca" concentration ([Ca"-1,) Ehrlich, 1988, 1991; Willard, 1992; Yue et al., 1992) , and immediate-early gene expression (Squint0 et al., 1989) . More recently, PAF has been shown to play a role in the development of the CNS, because a subunit of PAF acetylhydrolase, a PAF-inactivating enzyme, has 99% homology with the protein encoded by the gene causing Miller-Dieker lissencephaly, a disorder characterized by the absence of gyri and sulci in the cerebral cortex (Reiner et al., 1993; Hattori et al., 1994) .
Our previous study (Bito et al., 1992) showed that PAFR is expressed ubiquitously in the rat brain and functions in both neurons and non-neuronal cells in hippocampal cultures. Other studies showed that cultured astrocytes (Petroni et al., 1994) and microglia (Rhigi et al., 1995) respond to PAF. Thus, we assumed that PAFR in glia takes part in the PAF-related events in the CNS. In the present study, we attempted to localize PAFR in identified cell types of the rat brain by combining in situ hybridization and immunohistochemistry.
We then identified PAF-responsive glial cells in primary hippocampal cultures by measurement of PAF-elicited rise in [Ca"li, followed by immunocytochemistry.
We subsequently characterized PAFinduced release of arachidonic acid from microglia, which we found express the largest amount of PAFR mRNA. Our findings suggest a possible contribution of microglia to the PAFrelated events in the CNS.
MATERIALS AND METHODS
In situ hybdizution.
Sprague-Dawley rats (male, -250 gm) were anesthetized deeply with diethyl ether and decapitated. Brains were removed quickly, dissected coronally or parasagittally, embedded in OCT compound, and frozen in isopentane at -30°C. Ten-micrometer-thick coronal and parasagittal sections were made on a cryostat, thaw-mounted on poly-L-lysine (PLL)-coated slide glass, and air-dried for 10 min at room temperature. The sections were fixed in 4% paraformaldehyde buffered with 0.1 M phosphate buffer for 10 min, acetylated with 0.25% acetic anhydride, dehydrated in ethanol of ascending concentrations (70%, 95%, lOO%, and lOO%), and stored at ~80°C until use. Sections of rat whole embryos, embryonic day 18 (E18), and pup brains (PO, P7, P14, and P21) were prepared in the same procedures. In situ hybridization was carried out as described previously (Shigemoto et al., 1992) , with several modifications. Briefly, a PvuI-AvaI fragment (0.9 kb) of the coding region of rat PAF receptor cDNA (Bito et al., 1994) was subcloned into pBluescript II (Stratagene, La Jolla, CA) and linearized by BnmHI digestion. A "S-labeled cRNA probe was made with a cRNA svnthesizinn kit (Maxiscriut. Ambion, Austin, TX). The final i " \ radioactivity of the probe solution'was adjusted to 10' cp'mipl. After hybridization at 55°C for 6 hr in a humid chamber, the sections were washed in 2~ SSC at room temperature overnight and in 2~ SSC at 60°C for 1 hr, and they were treated with RNase A (20 &ml) at 37°C for 30 min in 0.5 M NaCl/lO mM Tris-Cl/l mM EDTA. The final wash was carried out in 0.1 X SSC at 67°C for 1 hr. The sections were dehydrated in ethanol of ascending concentrations (30%, 90%, lOO%, and 100%). The air-dried sections were autoradiographed on Hyperfilm-pmax (Amersham, Buckinghamshire, UK) or dipped in 1:l diluted NTB-2 emulsion (Kodak, Rochester, NY). The exposure periods were 10 d for the film and 6-7 weeks for the emulsion. The hybridization signals were evaluated by counting the number of silver grains per cell in the sections processed in the same procedures.
Immunohistochemistvy followed by in situ hybridization. To identify the most intensely labeled cells, the brain sections from adult rats were immunostaincd with a macrophage/microglia marker (0X-42, anti-CR-3 complement receptor antibody) or an astrocyte marker [antiglial fibrillary acidic protein (GFAP) antibody] bcforc in situ hybridization.
OX-42 (Serotec, Oxford, UK) and anti-GFAP antibody (G-3893, Sigma, St. Louis, MO) were affinity-purified twice with protein-G columns (Pharmacia, Uppsala, Sweden), because incubation with the crude antibodies substantially decreased mRNA signals of the subscqucnt in situ hybridization.
Cryostat sections (IO pm thick) of adult rat brains wcrc fixed serially in 4% paraformaldehyde buffered with 0. I M phosphate butfer, 50% aqueous acetone, 100% acetone, and 50% aqueous acetone (each for 2 min), and blocked with 0.1% nuclease-free bovine serum albumin (BSA) (Sigma) in PBS for 5 min at room temperature. Incubation with the purified primary antibodies (1:200) was carried out for 10 min at room temperature with 0.1% BSA/PBS. After three brief washes with PBS, the sections were incubated with biotinylated anti-mouse IgG antibody (1:200; Vector, Burlingame, CA) with 0.1% BSAiPBS for 10 min and subsequently with avidin-biotin-horseradish peroxidase complex (Vectastain Elite; Vector) for IO min, according to the manufacturer's instructions. Immunostaining was visualized with 1 mgiml diaminobenzidine tetrahydrochloride (DAB) in PBS containing 0.02% H,O1. The stained sections were then acetylated, dehydrated, and subjected to in situ hybridization, as described above. All of the immunostaining procedures were carried out under RNase-free conditions. Primary cell culture. Microglial cells were prepared from a primary culture of neonatal rat cerebral tissue, as described previously (Nakajima et al., 1989 . The purity of microglia was estimated to be >99% (data not shown) by staining with fluorescein isothiocyanate (FITC)-labeled isolectin B, (Sigma).
Neurons were prepared from embryonal (E16) rat neocortical tissues as described previously (Takei et al., 1991) . The purity of ncuronal cells was estimated to be >99.5% (data not shown) by staining with two monoclonal antibodies against neurofilament and microtubulc-associated protein 2 (MAP2) (Serotec).
Astrocytes were prepared from the brain of rat pups (P3) by the oreviouslv described method (Mori et al., 199(l) , with modifications. Nonastroglial cells were removed by shaking (MaCarthy and de Vellis, 1980) and subculturing twice. The final purity of astrocytes was estimated to be >99.5% (data not shown) by staining with anti-GFAP antibody. The maturity of neurons and astrocytes was confirmed by immunoreactivity of neurotilamcntiMAP2 and GFAP, respectively. Fibroblasts were prepared from pooled meninges of neonatal rat brains, as described previously (Saitoh et al., 1992) . The purity of fibroblastic cells was estimated to be >90% from the staining with anti-human fibronectin antiserum (Cappel-Organon Teknika, Belgium). Preparation of RNA and Northern blotlRT-PCR analyses for PAFR in primaty cell culture. Total cellular RNA was isolated from each culture by the guanidium thiocyanate/CsCl method (MacDonald et al., 1987) . The RNA samples (10 fig each) were electrophoresed in 1.2% agarose gel containing 7% formaldehyde and were alkaline-transferred onto a Hybond-N' membrane (Amersham). The blot membrane was incubated at 65°C in 10 ml rapid hybridization buffer (Amersham) for 30 min. A [3'P] dCTP-labeled probe was synthesized from the PvuI-AvaI fragment (0.9 kb) of rat PAF receptor cDNA with a random-primed DNA labeling kit (Ready-Prime, Amersham) and added to the hybridization buffer. After incubation on a shaker at 65°C for 2 hr, the membrane was washed in 50 ml of 2X SSC containing 0.1% SDS at room temperature for 30 min and in 1X SSC at 65°C for 30 min. The signals were detected by autoradiography on x-ray film. PAFR mRNA expression was evaluated further by reverse transcription-PCR (RT-PCR). The first-strand cDNA was synthesized from 1 kg of total RNA from each cell culture. Aliquots (1150) of the cDNA samples were amplified with PCR using rat PAFRspecific primers: CCGCTGTGGATTGTCTATTA (upstream, 5'-3') and AGGAGGTGATGAAGATGTGG (downstream, 5'-3') for 25,30, or 35 cycles with a thermal cycle of 58-72-94°C (each for I nun). The PCR products were electrophoresed in agarose gel and visualized by ethidiumbromide staining.
Fluorometric imaging of [Ca2+] , in primav cultures of rat microglia and hippocampal cells. Because PAFR mRNA expression was detected in the brain and primary cell culture systems, the functional presence of the receptor was then determined in cultured cells. Fluorometric measurement of intracellular Ca2+ concentration (]Ca" 1,) was carried out using primary cell cultures of (1) microglia isolated from culture of neonatal rat cerebrum and (2) hinnocamoal cells from El6 rat cmbrvos. PAFR oro-\,II .
tein itself could not be detected immunohistochemically hccause no anti-PAFR antibodies were available for this purpose.
(I) Microglia wcrc prcparcd as dcscribcd above and maintained on PLL-coated coverslips for 12-24 hr. The cell culture was loaded with 5 PM Fura 2-AM (Dojin Chemicals, Kumamoto, Japan) in glutamate-free DMEM (Nissui, Tokyo, Japan) containing fatty acid-fret 0. I % BSA (Sigma) at 37°C for I hr. Fluoromctric imaging was carried out with an invcrtcd microscope (TMD300, Nikon, Tokyo, Japan) cquippcd with Ruorcsccncc lenses Nikon) and an ICCD camera/ image analysis system (ARGUS-50; Hamamatsu Photonics, Hamamatsu, Japan) at 22-25°C. Eight frames (frame/O.03 set) were integrated, and ratio images (3401380 nm) were acquired cvcry IO sec. PAF (IO nM) was bath-applied in the HEPES-Tyrode bulfer (140 mM NaCI, 2.7 mM KCI, I .8 ITIM CaCI,, 12 mM NaHCO,, 5.6 mM o-glucose, 0.49 mM MgCI,, 0.37 mM NaH,PO,, 25 mM HEPES, pH 7.4) containing 0.1% BSA.
(2) Primary culture of hippocampal tissues was prepared from rat embryos (E16) as described previously (Banker and Cowan, 1977) with modifications. Briefly, hippocampal tissues were removed and treated with 1 mg/ml trypsin (Gibco, Gaithersburg, MD) and 0.5 mg/ml DNase I (Boehringer Mannheim, Germany) in 120 mM NaCI, 5 mM KCI, 25 mM D-glucose, 20 mtvt PIPES, pH 7.0, for 5 min at 37°C. The tissue suspension was centrifuged at 150 X g for 20 set, and the cell pellet was resuspended in 0.3 mg/ml trypsin inhibitor (Gibco) and 40 wgiml DNase I in the above buffer. After gentle trituration with a Pasteur pipette, the cells were centrifuged at 150 X g for 3 min. The cell pellet was resuspended in glutamate-free DMEM/lO% horse serum supplemented with 0.1 mg/ml transferrin (Sigma), 16 wgiml putrescinc (Sigma), 5 &ml insulin (Wako Chemicals, Osaka, Japan), 20 nM progesterone (Sigma), and 30 nM Na,SeO, (Sigma) (Bottenstein, 1985) and plated on polyethylene iminecoated coverslips with four-well silicon chambers (Flexiperm disk, Heraeus Biotechnology, Hanau, Germany) at I.0 X IO" ccllsiwell. The culture was maintained for 2 d in this medium and subsequently for IO-13 d in the medium containing 0.1% fatty acid-free BSA (Pentex, Miles, Kankakee, Illinois) in place of horse serum. The medium was changed every 3 d. Fluorometric Ca'+ imaging was carried out as described above. Before PAF application, the cells wcrc pretreated with 0.5 PM tetrodotoxin (Wako Chemicals) in the HEPES-Tyrodc butfcr containing 0.1% BSA. After [Ca'+], returned to the baseline level, Ca'+ imaging was repeated in some of the samples with application of 50 WM NMDA (Wako Chemicals) in the HEPES-Tyrode butTeriO. I % BSA to identity neuronal cells.
Immunocytochemical examinution of PAF-responsive hippvcampal cells. Immediately after the fluorometric imaging, the hippocampal cultures on the coverslips were washed briefly three times with PBS, fixed in 2% paraformaldehyde/PBS at room temperature for 5 min, washed three times with PBS, fixed in 100% methanol at -25°C for 30 set, and rinsed with PBS. Subsequently, the samples were incubated in 10% horse serum/PBS containing 0.1 mM each of CaCI,, MgCI,, and MnClz at room temperature for 10 mm and then in the samesolution containing 10 w"giml FITC-labeled isolectin B, and monoclonal anti-GFAP ( (Thomas, 1992; Nakajima and Kohsaka, 1993) . Northern blot analysis for cPLA, in primary cell culture. One of the important outputs of PAFR activation is release of arachidonic acid . Its release depends mainly on activation of cytosolic phospholipase Az (cPLA,) (Clark ct al., 1991) ; howcvcr, it has not been clear which cells in the brain express cPLA,.
One report showed that astrocytes alone are stained with an anti-cPLA, antibody (Stephenson et al., 1994) , but another showed cPLA, mRNA expression in neurons (Owada et al., 1994) . Because PAF stimulates arachidonic acid release in astrocytes (Petroni et al., 1994 ) and a myc-immortalized microglial cell line (Rhigi et al., 1995) , the presence of cPLA, was sought in primary cell culture systems. After sufficient time for decay of radioactivity, the membrane used in the analysis of PAFR mRNA expression was rehybridized with a probe synthesized from the coding region (-2.2 kb) of the mouse cPLA, cDNA (kindlv orovided bv Dr. I. Kudo. Showa Universitv. Tokyo).
The subsequent procedures were carried out as described above: Immunoblot analysis for cPLA, in micro&a. Microglial cells were isolated as described above (-2-4 X 10" cells/75 cm* flask). The medium was aspirated, and the cells were washed with ice-cold PBS. The flasks were cooled in liquid nitrogen and stored at ~80°C until use. The frozen cells were thawed and lysed by the addition of 200 kliflask lysis buffer containing protease inhibitors. The cell lysate was centrifuged at 15,000 X g for 10 min. and the resulting supernatant was treated with 5 X Laemmli buffer, boiled for 5 min, and subjected to 7.5% SDS-PAGE (20 mA/gel, 20 wg protein/lane).
After were found in the pyramidal cell layer and dentate gyrus (Fig. 2~ ).
In the cerebral cortex, intense signals were scattered randomly in all of the layers, and moderate signals were found in layers II-VI, with relative concentration to layers III, IV, and VI (Fig. 2h) . In the cerebellum, intense signals were scattered randomly as in the hippocampus, and slight to moderate signals were found in the granular cell and Purkinje cell layers (Fig. 2c,d ). The scattered distribution of the intense signals was evident throughout the whole brain in both gray and white matter. The signals were not highly concentrated in any specific brain areas or nerve nuclei. The intensity of the signals was constant in film autoradiographs among E18, PO, P7, P14, and P21 brains (data not shown). The distribution pattern of the signals was similar to that of the adult from P7 in the hippocampus (Fig. S-g ) and also in the other brain regions (data not shown).
Predominant expression of PAFR in microglia in rat brain The PAFR-expressing cells could be classified into at least two groups (Fig. 3u,h ). One type of cells was densely labeled and had small nuclei that stained darkly with cresyl violet. Most of these nuclei were of angular or irregular shapes. The cells of this group were scattered ubiquitously and randomly in both gray and white matter. These findings suggest that microglia comprise this group (de1 Rio-Hortega, 1932; Vaughan, 1984) . The other group of cells was labeled moderately and had larger nuclei that stained lightly. These cells were found most frequently in layers II-VI of the cerebral cortex but not in layer I. They were also found in the pyramidal cell layers of the hippocampus (Fig. 3n, indicated by an awow). These findings suggest that the second group includes neurons. No intense signals were found in cells with round and moderately stained nuclei, which characterize astrocytcs (de1 RioHortega, 1932; Vaughan, 1984) . Table I summarizes the intensity of the hybridization signals as evaluated by the number of grains per cell. The number of grains on microglia were outstanding from P7 to adult, exceeding more than twice those on neurons.
Immunohistochemistly followed by in sifu hybridization revealed that almost all of the densely labeled cells are OX-42-positive but anti-GFAP-negative in the adult rat brain (Fig. 3c-f ). This indicated that microglia express PAFR mRNA the most intensely; however, because all of the OX-42-positive cells were not labeled, microglia apparently are heterogeneous in terms of PAFR mRNA expression. On the other hand, all of the anti-GFAP-positive cells were labeled only slightly, if at all. Weak or moderate signals were found in 0X-42-and anti-GFAP-negative cells with large nuclei, which apparcntly were neurons (data not shown). The intensely labeled cells in the pup brain were also probably microglia. We could not confirm it successfully with immunohistochemistry, however, because immunostaining pup brain sections required longer incubation with the antibody, which diminished the signals of the following hybridization, possibly by degrading RNA.
Predominant expression of PAFR in cultured microglia Northern blot analysis revealed that PAFR mRNA expression is predominant in microglia and hardly detectable in neurons, astrocytes, and fibroblasts (Fig. 4) . In the RT-PCR analysis, the specific PCR product (-0.38 kb) apparently was detected in the RNA from microglia (225 cycles), astrocytes (230 cycles), and neurons (35 cycles) but not in fibroblasts (35 cycles) (Fig. 5) . The specificity of PCR amplification was confirmed by complete digestion of the products with EcoRV, whose restriction site was mapped in the middle of the amplified region of the PAF receptor cDNA (data not shown). 25 cycles Figure 5 . RT-PCR analysis of PAF receptor mRNA in primary cell culture of microglia, neurons, astrocytes, and fibroblasts prepared from rat brain. The first-strand cDNA was synthesized from I pg of total RNA from each cell culture. Aliquots (l/50) of the cDNA samples were amplified with PCR using rat PAFR-specific primers: CCGCTGTGGATT-GTCTATTA (upstream, 5'-3') and AGGAGGTGATGAAGATGTGG (downstream, 5'-3') for the indicated number of cycles with a thermal cycle of 58"C, 72"C, 94°C (each for 1 min). The PCR products were electrophoresed in agarose gel and visualized by ethidium-bromide staining. +X174 DNA-HaeIII digest was used as a DNA size marker.
PAF-elicited [Ca2+li response in cultured cells
finding was reproducible in >lO samples prepared from different embryos on different occasions. Immediately after fluorometry, the culture was stained simultaneously with isolectin B, for microglia and with anti-MAP2 antibody for neurons or an anti-GFAP antibody for astrocytes. More than 90% of the PAFresponsive cells were stained with isolectin B, but not with the anti-GFAP antibody, suggesting that they are mostly microglia. On the other hand, not all of the isolectin B,-positive cells responded to PAF, suggesting that the microglia in these conditions are heterogeneous in terms of PAFR expression. This is compatible with the results of immunohistochemistry followed by in situ hybridization. and showed MAP2 immunoreactivity ( Fig. 6f-h ), suggesting that some neurons express functional PAFR. Also, a small portion of these cells showed GFAP immunoreactivity (data not shown), suggesting that astrocytes also express functional PAFR, albeit to a much smaller degree.
Predominant expression of cPLA* in cultured microglia Northern blot analysis revealed that microglia predominantly express cPLA, mRNA (Fig. 7a) . The hybridization signals for neurons, astrocytes, and fibroblasts are scarcely visible in the figure but were detectable in the original autoradiograph. Additionally, the immunoblot analysis demonstrated that cPLA, protein is present in microglia (Fig. 7b) .
Arachidonic acid release from PAF-stimulated microglia The arachidonic acid release from microglia was dose-and timedependent. The optimal PAF concentration was 10 nM (Fig. Sa) , and the net (treated minus untreated) release reached a plateau in 10 min (Fig. 8b) . Preincubation with BAPTA-AM decreased the arachidonic acid release by -SO%, indicating that the release is partially dependent on [Ca2+], (Fig. 8b) . Fluorometric Ca2-' imaging confirmed that the BAPTA-AM treatment suppressed 10 nM PAF-elicited rise in [Ca2+], in microglia prepared on a coverslip (data not shown). In the HPLC/radiodetector analysis of the conditioned media of the microglia, all the radioactivity (-2 X lo4 cpm for PAF-treated microglia and -1 X lo4 cpm for untreated microglia) was eluted with the same retention time as standard arachidonic acid. No radioactivity peaks corresponding to prostaglandins or hydroxyeicosatetraenoic acids (HETEs) were detected in the medium of microglia incubated with or without 10 nM PAF (data not shown). Because this system detects 100 cpm radioactivity peaks, these results indicate that >99% of the released arachidonic acid remained unmetabolized. DISCUSSION Predominant PAFR expression in microglia Predominant expression of PAFR mRNA in microglia was demonstrated by i/r situ hybridization and Northern blot/RT-PCR analyses. PAFR mRNA expression in neurons was more apparent in in situ hybridization than in Northern blot analysis. This discrepancy may be ascribed to differences between the whole animal and primary cell culture systems. The results strongly suggest predominant presence of PAF receptor in microglia, although mRNA levels do not necessarily parallel the protein amount.
Fluorometric [Ca2+] , imaging revealed that PAF-responsive cells in primary hippocampal cultures were mostly microglia. We also confirmed the results of our previous report that a small number of neurons also respond to PAF (Bito et al., 1992) . The present results, taken together, show that microglia constitute the major population in the hippocampal cells that functionally express PAFR.
Predominant PAFR expression in microglia is a reasonable finding, because microglia are related to macrophages (Thomas, 1992; Nakajima and Kohsaka, 1993) , which have a large number of PAF receptors (Hayashi et al., 1991; Ring et al., 1993) and express PAFR mRNA intensely (Ishii et al., 1996) . This finding also seems relevant to the fact that in humans the leukocytes and brain express only PAFR transcript 1 (leukocyte type), one of the two different species of PAFR mRNA (Mutoh et al., 1993 (Mutoh et al., , 1996 , although splice variants for PAFR have not been studied in rats.
Immunohistochemistry followed by in situ hybridization revealed that PAFR is expressed in some OX-42-positive cells. In primary hippocampal cultures, PAF also elicited calcium response in some isolectin B,-positive cells. The cause of this heterogeneity is presently unclear. One possibility is that microglia are categorized into several subclasses of cells with different levels of PAFR expression. Another is that one microglial cell may change the level of PAFR mRNA expression, depending on certain factors. In fact, transcription of human PAFR transcript 1 in the brain is regulated by activation of protein kinase C (PKC) through NF-KB or by PAF itself (Mutoh et al., 1994) . Thus it is likely that various pathophysiological stimuli that activate PKC may induce PAFR mRNA expression in microglia.
PAFR expression in CNS development PAFR expression in the rat brain was constant, at least from E18. The characteristic pattern of in situ hybridization signals, i.e., scattered distribution of intensely labeled cells with small and dark-stained nuclei, was observed from P7. The involvement of PAF in CNS development has been suggested, because deficiency of a subunit of a PAF-inactivating enzyme results in Miller-Dieker lissencephaly or agyria (Reiner et al., 1993; Hattori et al., 1994) , a disorder attributable to incomplete migration of immature neurons to the cerebral cortex. There is also a hypothesis that microglia contribute to eliminating cells that die through developmentassociated cell death (Thomas, 1992) . In light of all of these events, PAF-activated microglia may play a role in developmental events in the CNS such as neuronal selection and migration.
Predominant expression of cPLA, in microglia In our primary cell culture systems, cPLA, was predominantly expressed in microglia, a finding in contrast to two previous reports. One showed that anti-cPLA, antibody exclusively stains astrocytes in the rat brain (Stephenson et al., 1994) , and the other showed by in situ hybridization that cPLA, mRNA is expressed in rat neurons after ischemia (Owada et al., 1994) . These discrepancies may be ascribed to the differences between the brain and cell culture and between mRNA and protein. Nevertheless, cPLA, in microglia deserves further attention, and the pathophysiological relevance of its function and transcriptional regulation needs to be evaluated.
Release and metabolism of arachidonic acid in PAF-treated microglia PAF-treated microglia efficiently released arachidonic acid, a finding compatible with the predominant PAFR and cPLA, expression in microglia. The optimal concentration of PAF for arachidonic acid release was 10 nM. The same concentration is also optimal for arachidonic acid release in CHO cells stably expressing the guinea pig PAFR gene . The release of arachidonic acid decreased by -50% after treatment with an intracellular Ca2+ chelator, BAPTA-AM.
The Ca"-dependence of PAF-induced arachidonic acid release agrees with the finding that cPLA, is activated when translocated to the membrane by a rise in [Ca2+], (Clark et al., 1991) . The increase in PLA, activity in the absence of Ca2+ rises might suggest the presence of Ca '+-independent PLA, in microglia, although we presently have no direct evidence for its presence. The released arachidonic acid was scarcely metabolized to its derivatives, e.g., HETEs, leukotrienes, and prostaglandins. These findings are in contrast to those obtained in peripheral macrophages and compatible with the recent report that PAF treatment of a mycimmortalized microglial cell line causes arachidonic acid release but no detectable production of 6-keto prostaglandin F,n and leukotriene B, (Rhigi et al., 199.5) .
Possible involvement of microglia in PAF effects on CNS Accumulated evidence has shown that PAF plays crucial roles in both physiological and pathological conditions in the CNS: PAF modulates synaptic transmission (Clark et al., 1992) , induces LTP (Wieraszko et al., 1993; Kato et al., 1994) , and contributes to neuronal cell injury (Panetta et al., 1989; Gilboe et al., 1991; Prehn and Krieglstein, 1993) . These PAF effects have been assumed as direct actions of PAF on neurons. Our findings, however, suggest that PAF-stimulated microglia also may be responsible at least in part for the known effects of PAF on neurons.
Microglia are known to affect neurons by releasing mediators, including r.eurotransmitters and neuromodulators, by phagocytosis, and by displacement of synapses (synaptic stripping) (Banati et al., 1993; Nakajima and Kohsaka, 1993) . In the case of PAFactivated microglia, one can speculate about the possible involvement of the following neurotransmitter/modulators in altering synaptic transmission. (1) Glutamate: This excitatory amino acid is released from activated microglia and causes neuronal cell death (Piani et al., 1991) . Whether it is released from PAFactivated microglia should be clarified in an additional study. (2) Arachidonic acid: This lipid messenger potentiates NMDA receptor currents (Miller et al., 1992) , induces LTP (Williams et al., 1989; Kato et al., 1991) , and inhibits the high-affinity glutamate uptake system in synaptosomes and astrocytes (Barbour et al., 1989; Volterra et al., 1992) . The present study revealed that PAF-stimulated microglia release arachidonic acid without notable conversion to its derivatives. (3) NO: This gaseous mediator induces LTP (Dawson and Snyder, 1994) and is also involved in microglia-mediated nerve cell injury (Boje and Arora, 1992; Chao et al., 1992; Merrill et al., 1993) . Whether PAF-activated microglia release NO remains to be clarified in a future study. (4) PAF: Microglia may release PAF itself, because PAF activates the cPLA, activity in microglia. If this were the case, PAF could serve as an autacoid messenger, thus forming a positive feedback loop. Simultaneous increase in both arachidonic acid and PAF may have synergistic effects on synaptic transmission. In addition to these mediators, there is a possibility that PAF-activated microglia release potentially cytotoxic substances such as free oxygen radicals, proteolytic enzymes, inflammatory cytokines, and unidentified neurotoxins. Indeed, microglia/macrophages, when activated by zymosan (Giulian et al., 1993b) , neuronal injury (Giulian et al., 1993a) , HIV infection (Giulian et al., 1990) , or gp120 protein (Lipton et al., 1991; Lipton, 1992) release neurotoxic factor(s) that act presumably through activation of NMDA receptors. We are now evaluating neurotoxicity of PAF-stimulated microglia and determining whether such neurotoxins are involved. On the other hand, phagocytosis and neuronal stripping by PAFactivated microglia have not been reported. Nevertheless, PAF injection into the mouse hippocampus induces morphological activation of microglia (Andersson ct al., 1992) . Because PAF (Panetta et al., 1989; Gilboe et al., 1991; Prehn and Krieglstein, 1993) and phagocytosis by microglia (Lees, 1993) both contribute to delayed neuronal cell death after ischemia, it is possible that microglia act as phagocytes to neurons in response to PAF produced after ischemia.
The present findings suggest the possibility that the PAFrelated events in the CNS arise not only from neuron-neuron interactions but also from a complex web of interactions between neurons and glia, in particular, microglia. To understand the roles of PAF in this web, one should first answer the following questions. (1) What are the outputs of PAFR activation in microglia and other cells? (2) Which cells, under which conditions, produce PAF? (3) How does PAF interact with other mediators, including NO and arachidonic acid? Monocytes-astroglia interactions reportedly produce PAF, arachidonic metabolites, and cytokines in HIV infection (Genis et al., 1992; Gelbard et al., 1994) . Furthermore, one should also answer the question about whether there are any PAF receptors other than the PAFR that was cloned in our laboratory, because the presence of distinct PAF binding sites in intracellular membranes has been reported (Bazan et al., 1993; Bazan, 1994) . Some of these critical questions will be answered shortly when PAFR-deficient mice are established and their phenotypes are analyzed. 
